Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00539_DB00872_nanopub.RAuhi8DYUPNE6Fngs9UiA1i4z-qogRMU4-HaBTXouGagk#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00539_DB00872 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00539_DB00872 label "DDI between Toremifene and Conivaptan - CYP3A4 Inhibitors (Strong) such as conivaptan may enhance the adverse/toxic effect of Toremifene. CYP3A4 Inhibitors (Strong) may increase the serum concentration of Toremifene. Concurrent use of toremifene with strong CYP3A4 inhibitors should be avoided. [drugbank_resource:DB00539_DB00872]" assertion.
- drugbank_resource:DB00539_DB00872 identifier "drugbank_resource:DB00539_DB00872" assertion.
- drugbank_resource:DB00539_DB00872 title "DDI between Toremifene and Conivaptan - CYP3A4 Inhibitors (Strong) such as conivaptan may enhance the adverse/toxic effect of Toremifene. CYP3A4 Inhibitors (Strong) may increase the serum concentration of Toremifene. Concurrent use of toremifene with strong CYP3A4 inhibitors should be avoided." assertion.
- drugbank:DB00539 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00539_DB00872 assertion.
- drugbank:DB00872 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00539_DB00872 assertion.